At a glance
ClinicalIndex Comparison RecordN/ACompleted· 64 enrolled
Drug / intervention
Kelulut Honey +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Use of Kelulut Honey for Carbohydrate-Loading in the Preoperative Period for Patients Undergoing Abdominal Surgery Involving the Digestive System as Part of Enhanced Recovery After Surgery as Opposed to VALENS® Carborie®Load
In Brief
A clinical study evaluating Kelulut Honey and Carborie for Insulin Resistance and ERAS. Completed, enrolled 64 participants across 1 site.
Detailed Summary
The study aims to identify if Kelulut Honey can be a potential alternative for the use of preoperative carboloading instead of the commercially available product, Carborie.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInsulin Resistance, ERAS
CountriesMalaysia
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedJun 2020
Enrollment StartOct 2020
Primary CompletionSep 2021
Study CompletionNov 2021
TodayJul 2026
First PostedJun 19, 2020
Enrollment StartOct 1, 2020
Primary CompletionSep 25, 2021
Study CompletionNov 30, 2021
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 6.0 years ago
Interventions
Kelulut Honeydietary
The Substance being tested to be used as an alternative
Carboriedietary
The commercially available substance